Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease
Abstract
No abstract availableKeywords
Funding Information
- NIH/NIAID (AI105170 (S.M.K.), AI093772 (S.M.K.))
This publication has 51 references indexed in Scilit:
- Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in MiceThe Journal of Infectious Diseases, 2011
- Biological challenges and technological opportunities for respiratory syncytial virus vaccine developmentImmunological Reviews, 2010
- Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c MiceJournal of Virology, 2010
- Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysisThe Lancet, 2010
- Comparison of Histochemical Methods for Murine Eosinophil Detection in an RSV Vaccine-enhanced Inflammation ModelToxicologic Pathology, 2009
- Differential Role of Gamma Interferon in Inhibiting Pulmonary Eosinophilia and Exacerbating Systemic Disease in Fusion Protein-Immunized Mice Undergoing Challenge Infection with Respiratory Syncytial VirusJournal of Virology, 2008
- Induction of Heterosubtypic Immunity to Influenza Virus by Intranasal ImmunizationJournal of Virology, 2008
- Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometryJournal of Immunological Methods, 2007
- A DNA transfection system for generation of influenza A virus from eight plasmidsProceedings of the National Academy of Sciences of the United States of America, 2000
- Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A virusesVirology, 1991